Catastrophic antiphospholipid syndromes in systemic lupus erythematosus

Renal Failure

Volumn 21, Issue 1, 1999, Pages 49-61

  Stratta, Piero ^a   Canavese, C ^a   Ferrero, S ^a   Grill, A ^a   Salomone, M ^b   Schinco, P C ^b   Fusaro, E ^a   Montaruli, B ^b   Santi, S ^a   Piccoli, G ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b St John Molinette Hospital ^*

Author keywords

Algorithm; Antiphospholipid antibodies; Clustering method; Factor V gene mutation; Lupus anticoagulant; Recursive partition; Systemic lupus Erythematosus; Thrombosis; 2 Glycoprotein 1

Indexed keywords

BETA2 GLYCOPROTEIN 1; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ALGORITHM; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE MUTATION; HIGH RISK PATIENT; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RISK FACTOR; SCHOOL CHILD; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0033010786     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229909066969     Document Type: Article

References (53)

1. Alving BM, Barr CF, Tang DB: Correlations between lupus anticoagulant and anticardiolipin antibodies in patients with associated partial thromboplastin time. Am J Med 88:112-116, 1990.
2. Triplett DA: Antiphospholipid and thrombosis: a consequence, coincidence or cause? Arch Pathol Lab Med 117:78-88, 1993.
3. Galli M, Finazzi G, Severs EM, Barbui T: Kaolin clotting time and dilute Russell's viper venom time distinguish between Prothrombin-dependent and β2-Glicoprotein I-dependent antiphospholipid antibodies. Blood 86:617-623, 1995.
4. Davies KA, Ireland H, Athanassiou P, Loizou S, Lane D, Walport MJ: Factor V Leiden mutation and venous thrombosis. Lancet 345:132-133, 1995.
5. De Groot PG, Derksen RHWM: Protein C pathway, antiphospholipid antibodies and thrombosis. Lupus 3:229-233, 1994.
6. Violi F, Ferro D, Valesini G: Thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 333:665, 1995.
7. Cuadrado MJ, Lopez-Pedrera C, Kamashtha MA, Camps MT, Tinahones F, Torres A, Hugues GRV, Velasco F: Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression. Arthritis Rheum 40:834-841, 1997.
8. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV: Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet ii:1211-1214, 1983.
9. Jungers P, Liote P, Dautzenberg MD, Gazengel C, Dougados M, Tron F, Bach JF: Lupus anticoagulant and thrombosis in systemic lupus erythematosus. Lancet i:574-575, 1984.
10. Glueck HI, Kotagal SK, Mark A, Weiss MD, Pollak VE, Miller MA, Coots M: Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 145:1389-1395, 1985.
11. Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in Systemic Lupus Erythematosus (SLE and in non-SLE disorders. Ann Int Med 112:682-698, 1990.
12. Vianna JL, Haga HJ, Tripathi P, Cervera R, Khamashta MA, Hughes GRV: Reassessing the status of antiphospholipid syndrome in systemic lupus erythema-tosus. Ann Rheum Dis 51:160-161, 1992.
13. Jouhikainen T, Stephansson E, Leirisalo-Repo M: Lupus anticoagulant as a prognostic marker in systemic lupus erythematosus. Br J Rheum 32:568-573, 1993.
14. Peck B, Hoffman GS, Franck WA: Trombophlebirtis in systemic lupus erythematosus. JAMA 240:172-175, 1978.
15. Angles-Cano E, Sultan Y, Clavvel J-P: Predisposing factor to thrombosis in systemic lupus erythematosus. Potential relation to endothelial cell damage. J Lab Clin Med 94:312-323, 1979.
16. Gladman DD, Urowitz MB: Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Rheum Dis 39:340-343, 1980.
17. Sturtfelt G, Nived O, Norberg R, Thorstensson R, Krook K: Anticardio-lipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 30:382-388, 1987.
18. Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR: Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 15:74-79, 1988.
19. Frampton G, Hicks J, Cameron JS: Significance of antiphospholipid antibodies in patients with lupus nephritis; Kidney Int 39:1225-1231, 1991.
20. Moroni G, La Marchesina U, Banfi G, Nador F, Vigano E, Marconi M, Lotto A, Ponticelli C: Cardiologic abnormalities in patients with long-term lupus nephritis. Clin Nephrol 43:20-28, 1995.
21. Asherson RA: The catastrophic antiphospholipid syndrome. J Rheumatol 19:508-512, 1992.
22. Tan EM, Cohen AS, Fries JF: The revised criteria for the classification of SLE. Arthritis Rheum 25:1271-1275, 1985.
23. Stratta P, Canavese C, Valmaggia P., Rotunno M, Levi E, Bulla A, Vercellone A: Coagulation and fibrinolysis in systemic Lupus erithematosus. Thromb Haemostas (Stuttgart) 46:575-580, 1981.
24. Churg J, Sobin LH: Lupus Nephritis. In: Churg J (ed): Renal disesase. Classification and Atlas of Glomerular Diseases. New York, NY, Igaku-Shoin, 1982, pp 127-149.
25. Sneddon JB: Cerebro-vascular lesions and livedo reticularis. Br J Dermato 77:180-184, 1965.
26. Remuzzi G, Ruggenenti P: The hemolytic uremic syndrome. Kidney Int 47:2-19, 1995..
27. Rosner E, Pauzner R, Lusky A, Modan M, Many A: Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 57:744-747, 1987
28. Exner T, Rickard K, Kronenberg H: A sensitive test demonstrating lupus anticoagulant and its behavioral patterns. Br J Haematol 40:143-151, 1978.
29. Harris EN: The second international andicardiolipin standardization workshop/the Kingston antiphospholipid antibody study (KAPS) group. Am J Clin Pathol 94:476-484, 1990.
30. Peto R, Pike P, Armitage M: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977.
31. Ciampi A, Lawless JF, Mckinney SM, Singhal K: Regression and recursive partition strategies in the analysis of medical survival data. J Clin Epidemiol 41:737-748, 1988.
32. Edworthy SM, Zatarain E, Mcshane DJ, Bloch DA: Analysis of the 1982 ARA lupus criteria data set by recursive partition methodology: new insight into the relative merit of individual criteria. J Rheumatol 15:1493-1498, 1988.
33. Goulet J-R, Mackenzie T, Levinton C, Hayslett JP, Ciampi A, Esdaile JM: The longterm prognosis of lupus nephritis: the impact of disease activity. J Rheumatol 20:59-65, 1993.
34. Stratta P, Canavese C, Thea A, Tognarelli G, Dogliani M, Porcu MC, Garis C, Borchiellini A, Schinco PC, Vercellone A: Clinical implication of antiphospholipid antibodies. In: Systemic Lupus Erythematosus. Contrib. Nephrol Sessa A, Mesoni M, Battini G, (eds) Basel, Karger; 99:123-125, 1992
35. Ishii Y, Nagasawa K, Mayumi T, Niho Y: Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematousus. Ann Rheum Dis 49:387-390, 1990.
36. Farrugia E, Torres VE, Gastineau D, Michel CJ, Holley KE: Lupus anticoagulant in systemic lupus erithematosus: a clinical and renal pathological study. Am J Kidney Dis XX:463-471, 1992.
37. Stratta P, Canavese C, Segoloni GP, Ferrero S, Grill A, Piccoli G: Shaded boundaries between antiphospholipid antibodies syndrome and lupus nephritis: low discriminating power of American Rheumatism Association Criteria? (letter) Clin Nephrol 47:138, 1997.
38. Zea Mendoza A, Rodriguez Garcia A, Irigoyen Oyarzabal MV, Vazquez Diaz M, Pardo Vigo A, Mampaso FM, Ortuno Mirete J: Anticuerpos anti-fosfolipido en el lupus eritematoso sistemico: incidencia, significacion y relaci6n con Ia nefritis lupica. Med Clin (Basel) 92: 724-728, 1989.
39. Perdiguero M, Boronat M, Marco P, Rivera F: The role of anti-phospholipid antibodies in lupus nephropathy. Nephron 71:35-39, 1995.
40. Much J, Herbst K, Rappaport S: Thrombosis in patients with the lupus anticoagulant. Ann Int Med 92:156-159, 1980.
41. Quereda C, Garcia Otero G, Pardo A, Orte L, Rivera M, Gonzalo A, Pascual J, Ortuno J: Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus. Am J Kidney Dis 23:555-561, 1994.
42. Asherson Ra, Khamashta MA, Baguley E, Oakley CM, Rowell NR, Hughes GRV: Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med 272:1103-1115, 1989.
43. Rosove MH, Brewer PMC: Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117:303-308, 1992.
44. Nicholls K, Kincaid-Smith P: Antiphospholipid syndrome and renal thrombotic microangiopathy. J Nephrol 8:123-125, 1995.
45. Gelfand J, Truong L, Stern L, Pirani CL, Appel GB: Thrombotic thrombo-cytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion. Am J Kidney Dis VI: 154-160, 1985.
46. Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min K-W, Silva F: Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis XX:150-158, 1992.
47. Kwaan HC: Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 24:71-81, 1987.
48. Perez RE, Mcclendon JR, Lie JT: Primary antiphospholipid syndrome with muftiorgan arterial and venous thrombosis. J Rheumatot 19:1289-1292, 1992.
49. Harris EN, Bos K: An acute disseminated coagulopathy-vasculopathy associated with the antyphospholipid syndrome. Arch Intern Med 151:231-232, 1991.
50. Asherson RA, Baguley E, Pal C, Hughes GRV: Antiphospholipid syndrome: five years follow up. Ann Rheum Dis 50:805-810, 1991.
51. Derksen RHWM, De Groot PHG, Nieuwenuis HK: Patients with antiphospholipid antibodies and venous thrombosis should receive longterm anticoagulant treatment. Ann Rheum Dis 52: 689-692, 1993.
52. Stratta P, Canavese C, Ferrero S, Grill A, Schinco PC, Monta-Ruli B: Failure of the war to the knife against antiphospholipid antibodies by conventional immunosuppressive therapy in systemic lupus erythematosus (letter). Clin Nephrol 46:356, 1996.
53. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BI, Hughes GRV: The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332: 993-997, 1995.